Systemic inflammatory biomarkers, particularly PLR and NLR, are significantly elevated in MG and correlate with disease severity and clinical subtypes. While PLR is associated with MG onset, NLR and thymoma are potential indicators for myasthenic crisis. These readily available markers may facilitate risk stratification in clinical practice.
Jin et al. (Tue,) studied this question.